State Street Corp Y M Abs Therapeutics, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 789,021 shares of YMAB stock, worth $3.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

789,021

Previous 1,314,409 39.97%

Holding current value

$3.33 Million

Previous $10.3 Million 66.04%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$4.43 - $8.17 $2.33 Million - $4.29 Million	-525,388 Reduced 39.97%	789,021 $3.5 Million
Q4 2024 Feb 14, 2025	BUY	$7.76 - $15.69 $811,913 - $1.64 Million	104,628 Added 8.65%	1,314,409 $10.3 Million
Q3 2024 Nov 14, 2024	BUY	$9.95 - $15.39 $4.03 Million - $6.24 Million	405,169 Added 50.36%	1,209,781 $15.9 Million
Q2 2024 Aug 14, 2024	BUY	$11.6 - $17.25 $621,052 - $923,547	53,539 Added 7.13%	804,612 $9.72 Million
Q1 2024 May 15, 2024	SELL	$6.57 - $18.69 $68,715 - $195,478	-10,459 Reduced 1.37%	751,073 $12.2 Million
Q4 2023 Feb 14, 2024	BUY	$4.88 - $7.42 $99,717 - $151,620	20,434 Added 2.76%	761,532 $5.19 Million
Q3 2023 Nov 14, 2023	SELL	$4.86 - $7.23 $17,053 - $25,370	-3,509 Reduced 0.47%	741,098 $4.04 Million
Q2 2023 Aug 14, 2023	SELL	$5.68 - $10.34 $103,506 - $188,425	-18,223 Reduced 2.39%	744,607 $5.06 Million
Q1 2023 May 15, 2023	SELL	$2.83 - $5.11 $196,178 - $354,230	-69,321 Reduced 8.33%	762,830 $3.82 Million
Q4 2022 Feb 14, 2023	SELL	$3.0 - $15.17 $3.26 Million - $16.5 Million	-1,086,988 Reduced 56.64%	832,151 $4.06 Million
Q3 2022 Nov 15, 2022	BUY	$13.96 - $19.67 $2.46 Million - $3.46 Million	175,997 Added 10.1%	1,919,139 $27.7 Million
Q2 2022 Aug 15, 2022	SELL	$8.22 - $15.13 $4.65 Million - $8.56 Million	-565,640 Reduced 24.5%	1,743,142 $26.4 Million
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $5.58 Million - $14.8 Million	852,112 Added 58.5%	2,308,782 $27.4 Million
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $1.93 Million - $3.66 Million	124,727 Added 9.36%	1,456,670 $23.6 Million
Q3 2021 Nov 15, 2021	SELL	$27.47 - $37.31 $1.58 Million - $2.15 Million	-57,568 Reduced 4.14%	1,331,943 $38 Million
Q2 2021 Aug 16, 2021	SELL	$25.45 - $37.64 $8.14 Million - $12 Million	-319,910 Reduced 18.71%	1,389,511 $47 Million
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $22.3 Million - $39.8 Million	766,418 Added 81.27%	1,709,421 $51.7 Million
Q4 2020 Feb 16, 2021	SELL	$37.86 - $54.26 $4.05 Million - $5.8 Million	-106,933 Reduced 10.18%	943,003 $46.7 Million
Q3 2020 Nov 10, 2020	BUY	$35.13 - $43.62 $3.31 Million - $4.12 Million	94,347 Added 9.87%	1,049,936 $40.3 Million
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $3.96 Million - $8.28 Million	167,194 Added 21.21%	955,589 $41.3 Million
Q1 2020 May 11, 2020	BUY	$14.39 - $35.8 $11.3 Million - $28.2 Million	788,395 New	788,395 $20.6 Million

Others Institutions Holding YMAB

# of Institutions

104

Shares Held

27.1M

Call Options Held

38.4K

Put Options Held

2.1K

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $184M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Y M Abs Therapeutics, Inc. Transaction History